Biomm SA
BOVESPA:BIOM3

Watchlist Manager
Biomm SA Logo
Biomm SA
BOVESPA:BIOM3
Watchlist
Price: 8.79 BRL -2.66% Market Closed
Market Cap: 1.1B BRL
Have any thoughts about
Biomm SA?
Write Note

Intrinsic Value

BIOM3's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one BIOM3 stock under the Base Case scenario is 5.32 BRL. Compared to the current market price of 8.79 BRL, Biomm SA is Overvalued by 39%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BIOM3 Intrinsic Value
5.32 BRL
Overvaluation 39%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Biomm SA

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for BIOM3 cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about BIOM3?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Biomm SA

Provide an overview of the primary business activities
of Biomm SA.

What unique competitive advantages
does Biomm SA hold over its rivals?

What risks and challenges
does Biomm SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Biomm SA.

Provide P/S
for Biomm SA.

Provide P/E
for Biomm SA.

Provide P/OCF
for Biomm SA.

Provide P/FCFE
for Biomm SA.

Provide P/B
for Biomm SA.

Provide EV/S
for Biomm SA.

Provide EV/GP
for Biomm SA.

Provide EV/EBITDA
for Biomm SA.

Provide EV/EBIT
for Biomm SA.

Provide EV/OCF
for Biomm SA.

Provide EV/FCFF
for Biomm SA.

Provide EV/IC
for Biomm SA.

Compare the intrinsic valuations
of Biomm SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Biomm SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Biomm SA compared to its peers.

Compare the P/E ratios
of Biomm SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Biomm SA with its peers.

Analyze the financial leverage
of Biomm SA compared to its main competitors.

Show all profitability ratios
for Biomm SA.

Provide ROE
for Biomm SA.

Provide ROA
for Biomm SA.

Provide ROIC
for Biomm SA.

Provide ROCE
for Biomm SA.

Provide Gross Margin
for Biomm SA.

Provide Operating Margin
for Biomm SA.

Provide Net Margin
for Biomm SA.

Provide FCF Margin
for Biomm SA.

Show all solvency ratios
for Biomm SA.

Provide D/E Ratio
for Biomm SA.

Provide D/A Ratio
for Biomm SA.

Provide Interest Coverage Ratio
for Biomm SA.

Provide Altman Z-Score Ratio
for Biomm SA.

Provide Quick Ratio
for Biomm SA.

Provide Current Ratio
for Biomm SA.

Provide Cash Ratio
for Biomm SA.

What is the historical Revenue growth
over the last 5 years for Biomm SA?

What is the historical Net Income growth
over the last 5 years for Biomm SA?

What is the current Free Cash Flow
of Biomm SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Biomm SA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Biomm SA

Current Assets 286.5m
Cash & Short-Term Investments 186.9m
Receivables 50.7m
Other Current Assets 49m
Non-Current Assets 217.6m
Long-Term Investments 8.7m
PP&E 166.5m
Intangibles 41.6m
Other Non-Current Assets 856k
Current Liabilities 72.1m
Accounts Payable 21m
Accrued Liabilities 8.6m
Other Current Liabilities 42.5m
Non-Current Liabilities 127.4m
Long-Term Debt 92.2m
Other Non-Current Liabilities 35.2m
Efficiency

Earnings Waterfall
Biomm SA

Revenue
123.8m BRL
Cost of Revenue
-95.8m BRL
Gross Profit
27.9m BRL
Operating Expenses
-104.6m BRL
Operating Income
-76.7m BRL
Other Expenses
-1.7m BRL
Net Income
-78.3m BRL

Free Cash Flow Analysis
Biomm SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

BIOM3 Profitability Score
Profitability Due Diligence

Biomm SA's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

ROE is Increasing
Positive 3-Years Revenue Growth
Positive Gross Profit
Positive 1-Year Revenue Growth
23/100
Profitability
Score

Biomm SA's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

BIOM3 Solvency Score
Solvency Due Diligence

Biomm SA's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
High Altman Z-Score
Low D/E
Long-Term Solvency
61/100
Solvency
Score

Biomm SA's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BIOM3 Price Targets Summary
Biomm SA

There are no price targets for BIOM3.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for BIOM3?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for BIOM3 is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Biomm SA Logo
Biomm SA

Country

Brazil

Industry

Biotechnology

Market Cap

1.1B BRL

Dividend Yield

0%

Description

BIOMM SA engages in the research, development, and manufacture of insulin. The company is headquartered in Nova Lima, Minas Gerais. The company went IPO on 2002-09-05. The firm is principally engaged in the development and licensing of technology for the production of human insulin and other recombinant proteins. The Company’s technology is suitable for the production of therapeutic proteins, which are used in the production of drugs and biopharmaceuticals. The Company’s technology for insulin production is protected by patents in various countries in Europe, Asia, North and South America. In addition, it is active in the development of production process of enzymes that are used in the hydrolysis of biomass and in the manufacture of bio-fuel. As of December 31, 2011, the Company’s subsidiaries were Biomm International Inc, Biomm Middle East Inc and Biomm Russia Ltd.

Contact

MINAS GERAIS
Nova Lima
Avenida Regent,n 705,Lote 15 ao 21, Alphaville
+553132991000
biomm.com

IPO

2002-09-05

Employees

-

Officers

CEO & Member of The Executive Board
Mr. Heraldo Carvalho Marchezini
Financial Director, IR & Member of Executive Board
Renato Arroyo Barbeiro
COO & Member of The Executive Board
Mr. Francisco Carlos Marques de Freitas
Commercial Director & Member of Executive Board
Mr. Francisco Rafael Costa Jr.
Accountant
Ms. Nayara Rodrigues de Souza Cruz
Controller
Ms. Mara Bertolin dos Santos Gomes

See Also

Discover More
What is the Intrinsic Value of one BIOM3 stock?

The intrinsic value of one BIOM3 stock under the Base Case scenario is 5.32 BRL.

Is BIOM3 stock undervalued or overvalued?

Compared to the current market price of 8.79 BRL, Biomm SA is Overvalued by 39%.

Back to Top